The agreement includes joint work in support of potential remedies and to identify effective ways to provide information and education to medical professionals and patients globally.
The University of Arizona (UA) is collaborating with OmegaGenesis to address common goals in testing remedies to address foot ulcers, providing education and in reducing amputations related to foot ulcers.
Oostur Raza, CEO of OmegaGenesis, said: “Through this collaboration we hope to reduce the number of amputations that result from diabetic foot ulcers by increasing education in developing countries and bringing treatments that will address this global problem to market quickly.”